MC1847A1 - Fragments d'interferons imnuns recombinants,homogenes et composition pharmaceutiques les contenant - Google Patents

Fragments d'interferons imnuns recombinants,homogenes et composition pharmaceutiques les contenant

Info

Publication number
MC1847A1
MC1847A1 MC871905A MC1905A MC1847A1 MC 1847 A1 MC1847 A1 MC 1847A1 MC 871905 A MC871905 A MC 871905A MC 1905 A MC1905 A MC 1905A MC 1847 A1 MC1847 A1 MC 1847A1
Authority
MC
Monaco
Prior art keywords
immun
interferons
recombinant
fragments
homogeneous
Prior art date
Application number
MC871905A
Other languages
English (en)
French (fr)
Inventor
Dobeli Heinz
Gentz Reiner
Hochuli Eric
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC1847A1 publication Critical patent/MC1847A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Pain & Pain Management (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
MC871905A 1986-08-13 1987-08-10 Fragments d'interferons imnuns recombinants,homogenes et composition pharmaceutiques les contenant MC1847A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868619725A GB8619725D0 (en) 1986-08-13 1986-08-13 Homogenous interferon fragments

Publications (1)

Publication Number Publication Date
MC1847A1 true MC1847A1 (fr) 1988-09-30

Family

ID=10602667

Family Applications (1)

Application Number Title Priority Date Filing Date
MC871905A MC1847A1 (fr) 1986-08-13 1987-08-10 Fragments d'interferons imnuns recombinants,homogenes et composition pharmaceutiques les contenant

Country Status (21)

Country Link
EP (1) EP0256424B1 (xx)
JP (1) JPS6349098A (xx)
KR (1) KR880002996A (xx)
AR (1) AR244808A1 (xx)
AT (1) ATE67783T1 (xx)
AU (1) AU607930B2 (xx)
DE (1) DE3773295D1 (xx)
DK (1) DK377787A (xx)
ES (1) ES2051714T3 (xx)
FI (1) FI873512A (xx)
GB (1) GB8619725D0 (xx)
GR (1) GR3003417T3 (xx)
HU (1) HU202920B (xx)
IE (1) IE60670B1 (xx)
IL (1) IL83474A0 (xx)
MC (1) MC1847A1 (xx)
NO (1) NO174631C (xx)
NZ (1) NZ221374A (xx)
PH (1) PH27432A (xx)
PT (1) PT85538B (xx)
ZA (1) ZA875819B (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2969461B2 (ja) * 1988-07-23 1999-11-02 株式会社林原生物化学研究所 ヒトγ−インターフェロンとその製造方法並びに用途
DE3730331A1 (de) * 1987-09-10 1989-03-30 Basf Ag Neue polypeptide, verfahren zur herstellung, die vektoren dafuer und arzneimittel daraus
WO1992004377A1 (en) * 1990-08-31 1992-03-19 Schering Corporation HUMAN INTERFERON-η4-134, FUNCTIONAL EQUIVALENTS THEREOF AND METHODS OF USING AND COMPOSITIONS EMPLOYING THESE MATERIALS
DE4036856C1 (xx) * 1990-11-19 1992-05-27 Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung Ev, 8000 Muenchen, De
US6258550B1 (en) 1993-04-23 2001-07-10 Virginia Commonwealth University Polypeptides that include conformation-constraining groups which flank a protein-protein interaction site
SK8292002A3 (en) 1999-11-12 2002-12-03 Maxygen Holdings Ltd A conjugate exhibiting interferon gamma activity, nucleotide sequence encoding for a polypeptide fraction of conjugate, an expression vector and a host cell containing nucleotide sequence, pharmaceutical composition comprising the same and use thereof
CN1309423C (zh) 1999-11-12 2007-04-11 马克西根控股公司 干扰素γ偶联物
US7959910B2 (en) 2000-07-31 2011-06-14 Biolex Therapeutics, Inc. C-terminally truncated interferon alpha variants
US6958388B2 (en) 2001-04-06 2005-10-25 Maxygen, Aps Interferon gamma polypeptide variants
US7038015B2 (en) 2001-04-06 2006-05-02 Maxygen Holdings, Ltd. Interferon gamma polypeptide variants
EP1539814A2 (en) 2002-07-03 2005-06-15 Maxygen Holdings Ltd. c/o Close Brothers (Cayman) Limited Full-length interferon gamma polypeptide variants
US20060024272A1 (en) * 2004-07-29 2006-02-02 Large Scale Biology Corporation C-terminally truncated interferon

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0788398B2 (ja) * 1983-10-17 1995-09-27 サントリー株式会社 新規生理活性ポリペプチドおよびその製造法
US4855238A (en) * 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
JPS60172999A (ja) * 1983-12-20 1985-09-06 Suntory Ltd 新規な塩基性ポリペプチドおよびその製造法
DK168016B1 (da) * 1983-12-26 1994-01-17 Kyowa Hakko Kogyo Kk Derivat af humant interferon-gamma-polypeptid
DE3414831A1 (de) * 1984-04-19 1985-10-31 Hoechst Ag, 6230 Frankfurt Herstellung von polypeptiden mit human-gammainterferon-aktivitaet
WO1985005618A1 (en) * 1984-06-06 1985-12-19 Takeda Chemical Industries, Ltd. Process for preparing interferon derivative
IL75302A0 (en) * 1984-06-06 1985-09-29 Takeda Chemical Industries Ltd Novel polypeptide and production thereof
JPS6124599A (ja) * 1984-07-11 1986-02-03 Kyowa Hakko Kogyo Co Ltd 新規ヒトインタ−フエロン−ｒポリペプチド誘導体
JPS6163696A (ja) * 1984-09-05 1986-04-01 Asahi Chem Ind Co Ltd 新しいペプチド
JPS61108397A (ja) * 1984-10-31 1986-05-27 Green Cross Corp:The インタ−フエロン−γ蛋白質の製造法
JPS62289600A (ja) * 1986-02-18 1987-12-16 Kanegafuchi Chem Ind Co Ltd インタ−フエロン−γ及びその製造方法

Also Published As

Publication number Publication date
NO873389D0 (no) 1987-08-12
ZA875819B (en) 1988-02-15
ES2051714T3 (es) 1994-07-01
GB8619725D0 (en) 1986-09-24
IL83474A0 (en) 1988-01-31
NO873389L (no) 1988-02-15
KR880002996A (ko) 1988-05-13
JPS6349098A (ja) 1988-03-01
PH27432A (en) 1993-06-21
DE3773295D1 (de) 1991-10-31
NO174631C (no) 1994-06-08
IE60670B1 (en) 1994-08-10
AR244808A1 (es) 1993-11-30
DK377787D0 (da) 1987-07-20
AU607930B2 (en) 1991-03-21
NO174631B (no) 1994-02-28
GR3003417T3 (en) 1993-02-17
FI873512A0 (fi) 1987-08-13
AU7668687A (en) 1988-05-19
HU202920B (en) 1991-04-29
EP0256424A1 (en) 1988-02-24
FI873512A (fi) 1988-02-14
EP0256424B1 (en) 1991-09-25
PT85538B (pt) 1990-06-29
HUT47148A (en) 1989-01-30
NZ221374A (en) 1990-07-26
DK377787A (da) 1988-02-14
PT85538A (en) 1987-09-01
ATE67783T1 (de) 1991-10-15
IE872160L (en) 1988-02-13

Similar Documents

Publication Publication Date Title
FR2604357B1 (fr) Composition pharmaceutique et cosmetique anti-acneique
IT8467445A1 (it) Composizione e preparato per la somministrazione di medicamenti per via cutanea.
IT1231434B (it) Composizione farmaceutica endovenosa e procedimento per la sua preparazione.
IT8321288A0 (it) Composizione farmaceutica contenente almeno in parte quantitativi terapeuticamente efficaci di endotossina detossificata raffinata ed il suo impiego terapeutico.
PT78732B (de) 13-alpha-alkylgonane deren herstellung und diese enthaltende pharmazeutische praeparate
FR2633182B1 (fr) Composition pharmaceutique anticancereuse et methode d'utilisation de l'invention
IL82265A (en) N-(2'-aminophenyl)-benzamide derivatives,their preparation and pharmaceutical compositions containing them
FR2586562B1 (fr) Composition pharmaceutique contenant de l'a-methylhistamine
NZ220020A (en) 1-hydroxy-2-pyridones and pharmaceutical composition
FR2626002B1 (fr) Nucleosides dideoxydidehydrocarbocycliques et composition pharmaceutique les contenant
MC1847A1 (fr) Fragments d'interferons imnuns recombinants,homogenes et composition pharmaceutiques les contenant
IT1239542B (it) Composizione farmaceutica comprendente piroxicam e procedimento per lasua preparazione
FR2567510B1 (fr) Composes d'aminophenol et compositions pharmaceutiques les contenant
FR2607502B1 (fr) Derives de l'imidazole, leur preparation et compositions medicamenteuses les contenant
IT1224574B (it) Fattore di attivazione di leucociti neutrofili, procedimento di preparazione, nonche' composizioni farmaceutiche che lo contengono
FR2626175B1 (fr) Composes nouveaux de 1,2-ethylenediamine et composition pharmaceutique les contenant
IT8468281A1 (it) Proglumide e composizioni farmaceutiche che la contengono per l'impiego nella terapia di affezioni neoplastiche.
NZ208669A (en) Human calcitonin 2, and pharmaceutical compositions
DK439589D0 (da) Fluorsubstituerede 4'-demethylepipodophyllotoksinderivater samt farmaceutiske praeparater indeholdende samme
EE9400337A (et) Alfainterferooni sisaldavad farmatseutilised kompositsioonid ja nende kasutusvõimalused
FR2528425B1 (fr) 1,4-dihydropyridines et composition pharmaceutique les contenant
FR2634764B1 (fr) Heterocycles oxaza et compositions pharmaceutiques les contenant
FR2611497B1 (fr) Agglomerats, leur preparation et compositions pharmaceutiques et/ou cosmetiques les contenant
IL82726A (en) Pharmaceutical compositions comprising anticonvulsively active 1-phenalkylimidazole-4-and/or-5-carboxamides and certain novel phenalkylimidazoles and their manufacture
NZ210567A (en) Pharmaceutical, veterinary and cosmetic compositions containing 2,4,6-triiodophenol

Legal Events

Date Code Title Description
YP Annual fee paid